Generate Biomedicines, Inc. (GENB)

NASDAQ: GENB · Real-Time Price · USD

15.03

-0.06 (-0.40%)

At close: Aug 13, 2026, 4:00 PM EDT

15.13

+0.10 (0.67%)

Pre-market: Aug 14, 2026, 5:41 AM EDT

Generate Biomedicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Aug '26 Aug 13, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Cap	1,929	-	-
Market Cap Growth	-	-	-
Enterprise Value	1,534	0	0
Debt / Equity Ratio	0.11	0.28	0.17
Net Debt / Equity Ratio	-0.87	0.25	0.73
Net Debt / EBITDA Ratio	1.58	0.69	1.74
Net Debt / FCF Ratio	1.62	0.75	2.61
Asset Turnover	0.06	0.08	0.04
Quick Ratio	8.08	2.69	4.55
Current Ratio	8.30	2.85	4.70
Return on Equity (ROE)	-77.83%	-82.06%	-51.13%
Return on Assets (ROA)	-58.83%	-55.37%	-37.96%
Return on Invested Capital (ROIC)	-419.78%	-636.87%	-516.19%
Return on Capital Employed (ROCE)	-69.71%	-69.18%	-45.63%
Buyback Yield / Dilution	-	-2.77%	-
Total Shareholder Return	-	-2.77%	-

SEC Filings: 10-K · 10-Q